Document is current
Any future updates will be listed below
-
Authors
Fernandez-Gonzalez, Sergi
Falo, Catalina
Pla, Maria J.
Campos, Miriam
Ortega-Exposito, Carlos
Ortega, Raul
Vicente, Maria
Petit, Ana
Bosch-Schips, Jan
Bajen, Maria Teresa
Reyes, Gabriel
Martínez, Evelyn
González-Viguera, Javier
Peñafiel, Judith
Stradella, Agostina
Pernas, Sonia
Ponce, Jordi
Garcia-Tejedor, Amparo
-
Funding
Funding for this research was provided by:
Universitat de Barcelona
- License Information
-
More Information
Article History
Received: 26 November 2023
Accepted: 30 January 2024
First Online: 18 April 2024
Declarations
:
: S. Fernandez-Gonzalez, C. Falo, M.J Pla, M. Campos, C. Ortega, R. Ortega, M. Vicente, A. Petit, J. Bosch, M.T Bajen, G. Reyes, E. Martínez, J. Gonzalez, J. Ponce and A. Garcia-Tejedor do not have any financial/non-financial interest. A.Stradella declares: •Speaker’s bureau: Daiichi, Novartis, Astra Zeneca •Travel, accommodations or expenses paid: Eisai, Novartis, and Pfizer •Advisory role: Astra Zeneca, Boehringer Ingelheim, Novartis, Seagen and Gilead •Non-financial disclosure: member of GEICAM's Executive Board S. Pernas declares: •Advisor/Consultant: AstraZeneca-Daiichi; Gebro; Pfizer; Pierre-Fabre; SeaGen •Speaker honoraria: AstraZeneca-Daiichi; Eisai; Gilead; Lilly; Novartis; Roche; •Travel grants from AstraZeneca-Daiichi; Pfizer; Gilead; Roche •Non-financial disclosure: member of SOLTI's Executive Board and Scientific Committee
: All authors declare that they have no financial interest.
: The study was approved by the ethics committee from our hospital (247/06).
: Informed consent was obtained from all individual participants included in the study to be treated and analyzed in our institution.
